Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors

European Journal of Endocrinology

Volumn 167, Issue 2, 2012, Pages 181-187

  De Laat, Joanne M ^a   Tham, Emma ^b   Pieterman, Carolina R C ^a   Vriens, MennoR ^a   Dorresteijn, Johannes A N ^a   Bots, MichielL ^a   Nordenskjod̈ld, Magnus ^b   Van Der Luijt, Rob B ^a   Valk, Gerlof D ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BRONCHUS TUMOR; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DUODENUM TUMOR; ENDOCRINE TUMOR; FAMILY HISTORY; FEMALE; GENE MUTATION; HUMAN; HYPOPHYSIS TUMOR; MAJOR CLINICAL STUDY; MALE; MEN1 GENE; MULTIPLE ENDOCRINE NEOPLASIA; NETHERLANDS; NEUROENDOCRINE TUMOR; PANCREATIC NEUROENDOCRINE TUMOR; PREDICTION; PREDICTION MODEL; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; STATISTICAL MODEL; STOMACH TUMOR; SWEDEN; THYMOMA; VALIDATION STUDY;

ADENOMA; ADULT; ALGORITHMS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DENMARK; ENDOCRINE GLAND NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEUROENDOCRINE TUMORS; PROGNOSIS; RISK FACTORS; SWEDEN; VALIDATION STUDIES AS TOPIC;

EID: 84864365548     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0210     Document Type: Article

References (22)

1. Golden SH, Robinson KA, Saldanha I, Anton B & Ladenson PW. Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. Journal of Clinical Endocrinology and Metabolism 2009 94 1853-1878. (doi:10.1210/jc.2008-2291)
2. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A & Evans DB. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. Journal of Clinical Oncology 2008 26 3063-3072. (doi:10.1200/JCO.2007.15.4377)
3. Lemos MC & Thakker RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Human Mutation 2008 29 22-32. (doi:10.1002/humu.20605)
4. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL & Marx SJ. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997 276 404-407. (doi:10.1126/science.276.5311.404)
5. Kouvaraki MA, Lee JE, Shapiro SE, Gagel RF, Sherman SI, Sellin RV, Cote GJ & Evans DB. Genotype-phenotype analysis in multiple endocrine neoplasia type 1. Archives of Surgery 2002 137 641-647. (doi:10.1001/archsurg.137.6.641)
6. Pieterman CR, Vriens MR, Dreijerink KM, van der Luijt RB &Valk GD. Care for patients with multiple endocrine neoplasia type 1: the current evidence base. Familial Cancer 2011 10 157-171. (doi:10.1007/s10689-010-9398-6)
7. Dean PG, van Heerden JA, Farley DR, Thompson GB, Grant CS, Harmsen WS & Ilstrup DM. Are patients with multiple endocrine neoplasia type I prone to premature death?World Journal of Surgery 2000 24 1437-1441. (doi:10.1007/s002680010237)
8. Doherty GM, Olson JA, Frisella MM, Lairmore TC, Wells SA Jr &Norton JA. Lethality of multiple endocrine neoplasia type I. World Journal of Surgery 1998 22 581-586. (doi:10.1007/s002689900438)
9. Geerdink EA, van der Luijt RB & Lips CJ. Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening? European Journal of Endocrinology 2003 149 577-582. (doi:10.1530/eje.0.1490577)
10. Goudet P, Murat A, Binquet C, Cardot-Bauters C, Costa A, Ruszniewski P, Niccoli P, Menegaux F, Chabrier G, Borson- Chazot F, Tabarin A, Bouchard P, Delemer B, Beckers A &Bonithon-Kopp C. Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients. World Journal of Surgery 2010 34 249-255. (doi:10.1007/s00268-009- 0290-1)
11. Lourenco DM Jr, Toledo RA, Coutinho FL, Margarido LC, Siqueira SA, dos Santos MA, Montenegro FL, Machado MC &Toledo SP. The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1. Clinics 2007 62 465-476. (doi:10.1590/S1807-59322007000400014)
12. Pieterman CR, Schreinemakers JM, Koppeschaar HP, Vriens MR, Rinkes IH, Zonnenberg BA, van der Luijt RB & Valk GD. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome. Clinical Endocrinology 2009 70 575-581. (doi:10.1111/j.1365-2265.2008. 03324.x)
13. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr & Marx SJ. Guidelines for diagnosis and therapy of MEN type 1 and type 2. Journal of Clinical Endocrinology and Metabolism 2001 86 5658-5671. (doi:10.1210/jc.86.12.5658)
14. Klein RD, Salih S, Bessoni J & Bale AE. Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory. Genetics in Medicine 2005 7 131-138. (doi:10.1097/01.GIM.0000153663.62300.F8)
15. Cardinal JW, Bergman L, Hayward N, Sweet A,Warner J, Marks L, Learoyd D, Dwight T, Robinson B, Epstein M, Smith M, Teh BT, Cameron DP & Prins JB. A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing. Journal of Medical Genetics 2005 42 69-74. (doi:10.1136/jmg.2003.017319)
16. Ellard S, Hattersley AT, Brewer CM & Vaidya B. Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing. Clinical Endocrinology 2005 62 169-175. (doi:10.1111/j.1365-2265.2005.02190.x)
17. Tham E, Grandell U, Lindgren E, Toss G, Skogseid B &Nordenskjold M. Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases. Journal of Clinical Endocrinology and Metabolism 2007 92 3389-3395. (doi:10.1210/jc.2007-0476)
18. Moons KG, Donders RA, Stijnen T & Harrell FE Jr. Using the outcome for imputation of missing predictor values was preferred. Journal of Clinical Epidemiology 2006 59 1092-1101. (doi:10.1016/j.jclinepi.2006.01.009)
19. Atkinson AC. A note on the generalized information criterion for choice of a model. Biometrika 1980 67 413-418. (doi:10.1093/biomet/67.2.413)
20. Moons KG, Royston P, Vergouwe Y, Grobbee DE & Altman DG. Prognosis and prognostic research: what, why, and how? BMJ 2009 338 b375. (doi:10.1136/bmj.b375)
21. Royston P, Moons KG, Altman DG & Vergouwe Y. Prognosis and prognostic research: developing a prognostic model. BMJ 2009 338 b604. (doi:10.1136/bmj.b604)
22. Altman DG, Vergouwe Y, Royston P & Moons KG. Prognosis and prognostic research: validating a prognostic model. BMJ 2009 338 b605. (doi:10.1136/bmj.b605)